Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 445 across all filing types
Latest filing 2024-05-30 Governance Information
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Corporate Governance Statement and Appendix 4G 31 pages 673.6KB
Governance Information Classification · 95% confidence The document is titled 'Corporate Governance Statement 2024' and extensively discusses the company's governance practices, board composition, roles and responsibilities, diversity policies, and board performance assessments. It references compliance with ASX Corporate Governance Principles and Recommendations. There is no indication of financial statements, audit results, earnings data, or other financial performance metrics. The content focuses on governance structures and policies rather than financial reporting or announcements. Therefore, this document fits the category of Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is a full governance report, not a brief announcement or summary.
2024-05-30 English
US Reschedules Cannabis 3 pages 643.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 2 May 2024 from Little Green Pharma Ltd. It discusses media reports about the US DEA's intention to reschedule cannabis from Schedule I to Schedule III, the implications of this change, and the potential impact on cannabis stocks including LGP. The document includes commentary on market reactions and share price graphs but does not contain any financial statements, detailed financial data, or regulatory filings. It is a news update or market-related announcement rather than a financial report or regulatory filing. The document length is 4510 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is a report publication announcement or a certification. The content is primarily an update on regulatory and market developments affecting the company. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for general regulatory announcements and miscellaneous filings that do not fit other categories.
2024-05-01 English
Investor Webinar & Presentation March 2024 Quarterly Reports 16 pages 2.2MB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 29 April 2024 from Little Green Pharma Ltd. It includes an investor webinar recording and an attached investor presentation. The content focuses on quarterly financial results (March quarter and FY24), operational updates, new products, and market developments. It contains detailed financial highlights such as revenue, cash receipts, operating cashflow, net tangible assets, and debt figures. The document is about quarterly activities and includes an Appendix 4C, which is a standard quarterly cash flow report for ASX-listed companies. The document is comprehensive and contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. It is not merely an announcement of a report or a brief summary, nor is it a full annual report or earnings release. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2024
2024-04-28 English
Quarterly Activities Report & Appendix 4C 15 pages 2.4MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report and Appendix 4C' for the quarter ending 31 March 2024. It contains detailed financial data such as revenue, cash receipts, operating cash flow, segment revenue, and cash flow statements. The presence of Appendix 4C, which is a quarterly cash flow report required by the ASX Listing Rules, confirms this is a quarterly financial report. The document is comprehensive, with substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2024
2024-04-16 English
Notification of cessation of securities - LGP 4 pages 14.8KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (cancellation) of certain securities (share rights) for LITTLE GREEN PHARMA LTD. It includes specifics such as the number of securities ceased, the reason for cessation, and updated issued capital figures. The document is an official announcement related to changes in the company's issued securities, specifically cessation of securities. It is not a financial report, audit, or management discussion, nor is it a voting result or dividend notice. It fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement to the ASX about securities cessation and does not fit other more specific categories like Share Issue/Capital Change (SHA) which typically covers new issues or capital increases rather than cessation/cancellation notifications. The document length is under 5,000 characters and is a direct announcement, not a report publication notice. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2024-04-15 English
Notification regarding unquoted securities - LGP 6 pages 18.5KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted securities under an employee incentive scheme by Little Green Pharma Ltd. It includes specifics such as the number of securities issued, issue dates, and references to ASX listing rules. The content is a formal notification of a securities issue rather than a financial report or earnings release. It does not contain financial statements or management discussion but focuses on capital changes related to securities issuance. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement but a formal notification of capital changes.
2024-04-15 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.